The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Infectious agents and Alzheimer's disease
Open accessAbstract
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Individuals affected by the disease gradually lose their capacity for abstract thinking, understanding, communication and memory. As populations age, declining cognitive abilities will represent an increasing global health concern. While AD was first described over a century ago, its pathogenesis remains to be fully elucidated. It is believed that cognitive decline in AD is caused by a progressive loss of neurons and synapses that lead to reduced neural plasticity. AD is a multifactorial disease affected by genetic and environmental factors. The molecular hallmarks of AD include formation of extracellular β amyloid (Aβ) aggregates, neurofibrillary tangles of hyperphosphorylated tau protein, excessive oxidative damage, an imbalance of biothiols, dysregulated methylation, and a disproportionate inflammatory response. Recent reports have shown that viruses (e.g., Herpes simplex type 1, 2, 6A/B; human cytomegalovirus, Epstein-Barr virus, hepatitis C virus, influenza virus, and severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), bacteria (e.g., Treponema pallidum, Borrelia burgdorferi, Chlamydia pneumoniae, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, Fusobacterium nucleatum, Aggregatibacter actinomycetemcmitans, Eikenella corrodens, Treponema denticola, and Helicobacter pylori), as well as eukaryotic unicellular parasites (e.g., Toxoplasma gondii) may factor into cognitive decline within the context of AD. Microorganisms may trigger pathological changes in the brain that resemble and/or induce accumulation of Aβ peptides and promote tau hyperphosphorylation. Further, the mere presence of infectious agents is suspected to induce both local and systemic inflammatory responses promoting cellular damage and neuronal loss. Here we review the influence of infectious agents on the development of AD to inspire new research in dementia based on these pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have shown that viral infections, such as Herpes simplex encephalitis, Epstein-Barr virus, Eastern Equine Encephalitis virus (EEEV), Western Equine Encephalitis virus (WEEV), and Venezuelan Equine Encephalitis Virus (VEEV), correlate with negative neurological consequences even after the acute phase”
From Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model (2024) · cites this paper as Piekut et al., 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“suggesting a potential role in developing and progressing neurodegenerative disorders, particularly AD (Bantle et al., 2019; Piekut et al., 2022; Ronca et al., 2017).”
From Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model (2024) · cites this paper as Piekut et al., 2022
In the citing paper
“Furthermore, SARS-CoV-2 directly induces AD pathogenesis such as neuronal damage and amyloid processing,278–280 as well as PD pathogenesis including α-syn aggregation and dopaminergic neuronal loss in various models.281”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [280]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
Marshall, B., & Warren, J. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91816-6 · Cited by 5,509
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,098
Nervous system involvement after infection with COVID-19 and other coronaviruses
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.031 · Cited by 2,046
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science · doi:10.1126/science.abd2985 · Cited by 1,925
Research works printed but not linked: 3
- Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M. World alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends updates. Alzheimer’s Disease International. 2015; 2015: 1–87.
- Boutoleau-Bretonnière C, Pouclet-Courtemanche H, Gillet A, Bernard A, Deruet AL, Gouraud I, et al. The effects of confinement on neuropsychiatric symptoms in alzheimer’s disease during the COVID-19 crisis. Journal of Alzheimer’s Disease. 2020; 76: 41–47. · DOI · Paper page
- Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und psychisch-gerichtliche Medizin. 1907; 18: 177–179. (In German)
Cited by
Virus exposure and neurodegenerative disease risk across national biobanks
Levine, K. S., Leonard, H. L., Blauwendraat, C., Iwaki, H., Johnson, N., Bandres-Ciga, S., Ferrucci, L., Faghri, F., Singleton, A. B., & Nalls, M. A. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.029 · Cited by 341
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“Furthermore, SARS-CoV-2 directly induces AD pathogenesis such as neuronal damage and amyloid processing, 278 – 280 as well as PD pathogenesis including α -syn aggregation and dopaminergic neuronal loss in various models.”
Rao, R. V., Subramaniam, K. G., Gregory, J., Bredesen, A. L., Coward, C., Okada, S., Kelly, L., & Bredesen, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021659 · Cited by 114
Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
Bruno, F., Abondio, P., Bruno, R., Ceraudo, L., Paparazzo, E., Citrigno, L., Luiselli, D., Bruni, A. C., Passarino, G., Colao, R., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102068 · Cited by 88
Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
Korczowska-Łącka, I., Słowikowski, B. K., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., Permoda-Pachuta, A., & Dorszewska, J. (2023) · Antioxidants · doi:10.3390/antiox12101811 · Cited by 98
Self-citationMelchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 86
The role of immune activation and antigen persistence in acute and long COVID
Opsteen, S., Files, J. K., Fram, T., & Erdmann, N. B. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231158041 · Cited by 73
Selected Biomarkers of Oxidative Stress and Energy Metabolism Disorders in Neurological Diseases
Korczowska-Łącka, I., Hurła, M., Banaszek, N., Kobylarek, D., Szymanowicz, O., Kozubski, W. P., & Dorszewska, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03329-4 · Cited by 63
“Receptors such as GPR43/FFAR2, GPR41/ FFAR3, and GPR109a/HCAR2 and transporters including MCT1/SLC16A1 and SMCT1/SLC5A8 are important for its operations [22, 23].”
BackgroundSelf-citationRapamycin Responds to Alzheimer’s Disease: A Potential Translational Therapy
Hou, S.-J., Zhang, S., Li, Y., & Xu, S.-Y. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s429440 · Cited by 61
“Infections with various pathogens (viruses, bacteria, parasites, and many other microorganisms), 45 surgery, critical illness, and dysbiosis of the gut microbiota can elicit a systemic immune response, which in turn triggers a central immune response.”
Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
Rudnicka-Drożak, E., Drożak, P., Mizerski, G., Zaborowski, T., Ślusarska, B. J., Nowicki, G., & Drożak, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032146 · Cited by 61
“The viral hypothesis of AD states that an exposure to viruses, such as Herpes Simplex type 1 and 2, Epstein–Barr virus, human cytomegalovirus, influenza virus, and hepatitis C virus, increases the risk of AD and plays an important role in the cognitive decline associated with this disease [7].”
BackgroundDo vaccinations influence the development of Alzheimer disease?
Bukhbinder, A. S., Ling, Y., Harris, K., Jiang, X., & Schulz, P. E. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2216625 · Cited by 34
Sian‐Hülsmann, J., & Riederer, P. F. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-023-02723-5 · Cited by 32
Schattner, A. (2024) · Pathogens · doi:10.3390/pathogens13080667 · Cited by 41
“Infectious agents, mostly viruses (including CMV), have been investigated in the context of Alzheimer’s disease since a key role of neuroinflammation in neurodegenerative diseases is increasingly recognized [132].”
BackgroundCurrent research progress on Prevotella intermedia and associated diseases
Zhang, S., Zhao, Y., Lalsiamthara, J., Peng, Y., Qi, L., Deng, S., & Wang, Q. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2390594 · Cited by 42
“…(taati Moghadam et al. 2022). it has also been proposed that P. intermedia and F. nucleatum may be a factor in the cognitive decline of AD patients (Piekut et al. 2022). in addition, periodontal disease is epidemiologically associated with some inflammation-driven diseases, such as…”
Microglial dysfunction in Alzheimer's disease: Mechanisms, emerging therapies, and future directions
Azmal, M., Paul, J. K., Prima, F. S., Haque, A. N. M. S. N. B., Meem, M., & Ghosh, A. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115374 · Cited by 32
He, Z., Tian, W., Wei, Q., & Xu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968649 · Cited by 33
Bhardwaj, S., Grewal, A. K., Singh, S., Dhankar, V., & Jindal, A. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01502-2 · Cited by 26
“Available evidence has reported that excessive accumulation of tau and amyloid proteins interferes with neurotransmission and reduces neuronal communication, responsible for AD-like symptoms (Piekut et al. 2022).”
Are there any completely sterile organs or tissues in the human body? Is there any sacred place?
Doña, A. M., Vazquez-Borrego, M. C., & Michán, C. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.14442 · Cited by 26
Janković, M. Z., Nikolić, D., Novaković, I. V., Petrovic, B., Lacković, M., & Santric-Milicevic, M. M. (2023) · Diagnostics · doi:10.3390/diagnostics13061091 · Cited by 28
Association between cytomegalovirus infection and neurological disorders: A systematic review
Sanami, S., Shamsabadi, S., Dayhimi, A., Pirhayati, M., Ahmad, S., Pirhayati, A., Ajami, M., Hemati, S., Shirvani, M., Alagha, A., et al. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2532 · Cited by 25
Human brain organoids to explore SARS‐CoV‐2‐induced effects on the central nervous system
Ostermann, P. N., & Schaal, H. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2430 · Cited by 24
Mérida-Vieyra, J., Ranero, A. D. C., Palacios-Reyes, D., Murata, C., & Aquino-Andrade, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-48701-5 · Cited by 22
Zeng, H., Zhou, K., Zhuang, Y., Li, A., Luo, B., & Zhang, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1273104 · Cited by 19
“AD had been reported to be associated with infections caused by herpes simplex virus, spirochetes, Chlamydia pneumoniae , and fungi (Piekut et al., 2022).”
BackgroundHosseininasab, S. S. M., Ebrahimi, R., Yaghoobpoor, S., Kazemi, K., Khakpour, Y., Hajibeygi, R., Mohamadkhani, A., Fathi, M., Vakili, K. G., Tavasol, A., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1513095 · Cited by 21
A review of the roles of pathogens in Alzheimer’s disease
Zhao, M., Wang, Y., Shen, Y., Wei, C., Zhang, G., & Sun, L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1439055 · Cited by 19
Frontera, J. A., Guekht, A. B., Allegri, R., Ashraf, M., Baykan, B. B., Crivelli, L., Easton, A., García‐Azorín, D., Helbok, R., Joshi, J., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120827 · Cited by 17
The relationship between microRNAs and COVID-19 complications
Kebriaei, A., Besharati, R., Ahmadabad, H. N., Havakhah, S., Khosrojerdi, M., & Azimian, A. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.08.007 · Cited by 16
“Infections caused by viruses, bacteria, or other pathogens in the nervous system have demonstrated the potential to initiate or expedite neurodegeneration and neuroinflammation, leading to various clinically significant symptoms [75,76].”
BackgroundThe role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer’s disease
Salminen, A. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02504-x · Cited by 17
SARS-CoV-2 Invasion and Pathological Links to Prion Disease
Lukiw, W. J., Jaber, V. R., Pogue, A. I., & Zhao, Y. (2022) · Biomolecules · doi:10.3390/biom12091253 · Cited by 16
SARS-CoV-2, long COVID, prion disease and neurodegeneration
Zhao, Y., Jaber, V. R., & Lukiw, W. J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1002770 · Cited by 16
“‘S1’ spike proteins TABLE 1 Human neurological diseases and/or syndromes associated with ‘long COVID’; recent reports of age-related, progressive, terminal and/or incapacitating neurological disorders associated with SARS-CoV-2 infection and COVID-19; the majority of these most recent reports involve COVID-19 with the…”
BackgroundMilmed Yeast Alters the LPS-Induced M1 Microglia Cells to Form M2 Anti-Inflammatory Phenotype
Armeli, F., Mengoni, B., Maggi, E., Mazzoni, C., Preziosi, A., Mancini, P., Businaro, R., Lenz, T., & Archer, T. (2022) · Biomedicines · doi:10.3390/biomedicines10123116 · Cited by 15
“Moreover, it has recently been hypothesized that microorganisms may contribute to the development of Alzheimer’s disease, either by producing amyloid-like molecules, enhancing the production of endogenous Aβ, or by increasing systemic inflammation that, targeting glial cells, contributes to the neuronal damage observe…”
BackgroundCandelli, M., Franza, L., Cianci, R., Pignataro, G., Merra, G., Piccioni, A., Ojetti, V., Gasbarrini, A., & Franceschi, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417520 · Cited by 14
Alzheimer's disease and herpes viruses: Current events and perspectives
Pinchera, B., Filippo, I. D., Cuccurullo, F., Salvatore, E., & Gentile, I. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2550 · Cited by 20
From coughs to complications: the story of Chlamydia pneumoniae
Tagini, F., Puolakkainen, M. H., Greub, G., & on behalf of the ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002006 · Cited by 14
“This is to be put in perspective with many other pathogens that have been previously linked with Alzheimer’s disease [37].”
Choi, C., Gadhave, K., Villano, J., Pekosz, A. S., Mao, X., & Jia, H. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29349 · Cited by 14
Gansemer, B. M., Rahman, M. T., Zhang, Z., & Green, S. H. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1389816 · Cited by 12
“For example, it has been shown that bacteria are present in the brain of Alzheimer’s disease patients (Emery et al., 2017) and the infection by bacteria and/or viruses may contribute to the pathogenesis of Alzheimer’s disease (Piekut et al., 2022).”
BackgroundOh my gut! Is the microbial origin of neurodegenerative diseases real?
Walker, A. C., & Czyż, D. M. (2023) · Infection and Immunity · doi:10.1128/iai.00437-22 · Cited by 12
Min, J.-H., Sarlus, H., & Harris, R. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1467333 · Cited by 14
Jing, L., Lu, Q., Sun, B., Shao, N., Huang, W. G., Hu, G., Cai, B., & Si, W. (2023) · 3 Biotech · doi:10.1007/s13205-023-03769-8 · Cited by 10
“The pathogenesis of AD involves ferroptosis (Wang et al. 2022), oxidative stress, excitatory neuronal toxicity, inflammatory response, and apoptosis (Piekut et al. 2022).”
BackgroundLiu, S., Yan, Z., Peng, Y., Liu, Y., Li, Y., Xu, D., Gong, Y., Cui, Z., Wu, Y., Zhang, Y., et al. (2023) · Parasites & Vectors · doi:10.1186/s13071-023-06023-5 · Cited by 10
“Accordingly, these animals exhibited cognitive deficits, including disrupted memory and learning and altered social novelty recognition [8].”
BackgroundNeurologic Complications of Influenza and Potential Protective Vaccine Effects
Falsey, A. R. (2025) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70071 · Cited by 11
Infectious viruses and neurodegenerative diseases: The mitochondrial defect hypothesis
Jiang, T., Zhu, K., Kang, G., Wu, G., Wang, L., & Tan, Y. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2565 · Cited by 12
Fongsaran, C., Jirakanwisal, K., Peng, B.-H., Fracassi, A., Taglialatela, G., Dineley, K. T., Paessler, S., & Cisneros, I. E. (2024) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2024.100780 · Cited by 9
VanderGiessen, M., de Jager, C., Leighton, J., Xie, H., Theus, M. H., Johnson, E. A., & Kehn‐Hall, K. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1514940 · Cited by 10
Analysis of the Association Between Pathogen Exposure and the Risk of Dementia
Fu, J., Wei, Q., Chen, X., Lai, X., & Shang, H. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240073 · Cited by 10
m5C RNA methylation: a potential mechanism for infectious Alzheimer’s disease
Teng, S., Han, C., Zhou, J., He, Z., & Qian, W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1440143 · Cited by 10
The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological Diseases
Kryńska, K., Kuliś, K., Mazurek, W., Gudowska-Sawczuk, M., Zajkowska, M., & Mroczko, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168715 · Cited by 9
“Alzheimer’s disease has been repetitively associated with viral etiology [89].”
BackgroundCalabria, F. F., Leporace, M., Cimini, A., Ricci, M., Travascio, L., & Bagnato, A. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206172 · Cited by 8
The association between rs6859 in NECTIN2 gene and Alzheimer’s disease is partly mediated by pTau
Rajendrakumar, A. L., Arbeev, K. G., Bagley, O., Yashin, A. I., & Ukraintseva, S. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1388363 · Cited by 8
“…to infections and neurodegeneration is increasing (Yashin et al., 2018; Yong et al., 2021; Cairns et al., 2022; Mancuso et al., 2022; Nuovo et al., 2022; Piekut et al., 2022; Sathler et al., 2022; Tang et al., 2022; Goldhardt et al., 2023; Ukraintseva et al., 2023; Popov et al., 2024).”
Boziki, M. K., Theotokis, P., Kesidou, E., Nella, M., Bakirtzis, C., Karafoulidou, E., Tzitiridou‐Chatzopoulou, M., Doulberis, M., Kazakos, E. I., Deretzi, G., et al. (2024) · Neurology International · doi:10.3390/neurolint16060127 · Cited by 9
“Helicobacter pylori ( Hp ) is a Gram-negative, microaerophilic spiral-shaped and fl agel-lated [63] bacterium, prevalent in about 58% of the world’s population [64], being implicated in the pathogenesis of duodenal and gastric ulcer disease, as well as of gastric malignancies [65].”
Enterovirus infection and its relationship with neurodegenerative diseases
Junior, I. P. D. S., & Vieira, T. C. R. G. (2023) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760220252 · Cited by 9
“Over the past decades, infections caused by numerous infectious agents have been associated with the pathogenesis of NDs, although this idea is still controversial.(36) To date, little is known about the potential contribution of enteroviruses in the development of NDs through neuroinflammatory pathways or aggravating…”
BackgroundUnraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease
Li, X., Li, Z., Chen, H., Guo, H., Ge, Y., Dong, F., Zhang, F., & Zhang, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115199 · Cited by 8
Altered Synaptic Plasticity: Plausible Mechanisms Associated With Viral Infections
Saini, V., Rani, A., Kumar, A., Jha, K., Karnati, S., & Jha, H. C. (2023) · Future Virology · doi:10.2217/fvl-2023-0105 · Cited by 7
Lewis, J. E., McDaniel, H. R., Woolger, J. M., & Khan, S. A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230659 · Cited by 9
Phase Separation of SARS-CoV-2 Nucleocapsid Protein with TDP-43 Is Dependent on C-Terminus Domains
Strong, M. J., McLellan, C., Kaplanis, B., Droppelmann, C. A., & Junop, M. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168779 · Cited by 10
From Infection to Inoculation: Expanding the Microbial Hypothesis of Alzheimer’s Disease
Dorszewska, J., Hurła, M., Banaszek, N., Kobylarek, D., Piekut, T., & Kozubski, W. P. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230202155404 · Cited by 6
Self-citationAliashrafi, M., Nasehi, M. M., Siadat, S. D., Mohammadi-Mahdiabadi-Hasani, M.-H., Zali, H., & Niknam, Z. (2024) · Behavioral and Brain Functions · doi:10.1186/s12993-024-00257-8 · Cited by 7
“In two AD case reports, combination treatment with cephalosporine, estrogen and enalapril against C. acnes resulted in memory improvement and clinical symptoms stabilization [13, 14].”
Yang, J., Ren, W., Ren, Y., Yu, T., & Ali, L. (2025) · npj Aging · doi:10.1038/s41514-025-00212-5 · Cited by 6
“Among the elderly, cognitive ability decline like Alzheimer ’ s disease (AD) and dementia would be caused by the in fl uenza infection, which may induce the pathological lesions in brain 120 .”
SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
Zhao, Y., & Lukiw, W. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.937961 · Cited by 6
“Long-lasting neurological consequences after SARSCoV-2 infection negatively impacts the brain and CNS in anatomical regions known to be targeted by neurodegenerative events, as is observed throughout all phases of the AD continuum (Lingor et al., 2022; Lukiw et al., 2022; Piekut et al., 2022; Sirin et al., 2022; Szabo…”
BackgroundInfluentialKordi, R., Andrews, T. J., & Hicar, M. D. (2025) · Virology · doi:10.1016/j.virol.2025.110523 · Cited by 7
Association of Cognitive Impairment With Chronic Viral Hepatitis Among Older Adults in Taiwan
Su, F., Su, M.-J., Yu, M.-Z., Maliko, M., & Yeh, C. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.09.011 · Cited by 6
The association of microbial infection and adaptive immune cell activation in Alzheimer’s disease
Clement, M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad015 · Cited by 6
Agents at the Peak of US FDA Approval for the Treatment of Alzheimer’s Disease
Alam, J., Kalash, A., Hassan, M. I., & Rahman, S. Z. (2024) · Neurological Research · doi:10.1080/01616412.2024.2302271 · Cited by 8
“Currently, the AD patho-mechanism includes beta-amyloid (Aβ) & tau cascades, cholinergic insufficiency & synaptic dysfunction, neuroinflammation & oxidative stress, and other biomarkers such as vascular abnormalities and infectious factors [5].”
BackgroundUntersteiner, H., Wurm, R., Reichardt, B., Goeschl, S., Berger–Sieczkowski, E., König, T., Parvizi, T., Silvaieh, S., & Stögmann, E. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.92 · Cited by 6
Jászberényi, M., Thurzó, B., Jayakumar, A. R., & Schally, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313086 · Cited by 5
“Infections by neurotropic viruses, as triggering factors in the development of neurodegenerative disorders (e.g., post-encephalitic Parkinsonism after encephalitis lethargica caused by influenza) have already been suggested [61–63].”
Kanwal, A., Shah, M., Khan, M. U., Latif, M., Anum, H., Younas, S., Aljasham, A. T., & Ojha, S. C. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12105-9 · Cited by 6
“P. intermedia has been linked to several disorders, including knee osteoarthritis [8], neurological diseases [9, 10], respiratory diseases [7, 11], and circulatory diseases [12–14].”
Kaiumov, K. A., Lyamin, A. V., Zhestkov, A. V., & Владимировна, Б. И. (2023) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2023.1.13-18 · Cited by 5
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases
Grahl, M. V. C., Hohl, K. S., Smaniotto, T. Â., & Carlini, C. R. (2025) · Molecules · doi:10.3390/molecules30030687 · Cited by 5
The role of nuclear medicine in neurodegenerative diseases: a narrative review
Riahi, F., & Fesharaki, S. (2025) · American Journal of Neurodegenerative Disease · doi:10.62347/soge3962 · Cited by 5
Altered oral health and microbiota in drug-free patients with schizophrenia
Huang, H., Yang, N.-Y., Chen, M., Chen, X., Chen, W. J., Li, X., Chen, Y., Deng, Z., Zhou, W., Xu, S., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06633-6 · Cited by 5
“The inflammatory response triggered by oral pathogens may lead to chronic systemic inflammation, which, in turn, exacerbates central nervous system inflammation and promotes neuropsychiatric disorder progression through complex pathways [81, 82].”
Rangel, G. A., Muñoz, B. A., Ramirez, M., Wroblewski, K., Villarreal, A. E., Oviedo, D. C., Carreira, M. B., McLeod, R. L., & Britton, G. B. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251361066 · Cited by 4
Exploring the role of multi-pathogen infections in Alzheimer’s disease: A case–control study
García-Bustos, V., Cabañero-Navalón, M. D., Lloret-Sos, C., Gómez, M., Baquero, M., Ibanez-Barcelo, S., Lodares, J. G., & Cháfer‐Pericás, C. (2025) · Virulence · doi:10.1080/21505594.2025.2560904 · Cited by 5
Knockdown of DJ-1 Exacerbates Neuron Apoptosis Induced by TgCtwh3 through the NF-κB Pathway
Yang, D., Wu, M., Zou, N., Tang, Y., Tao, Q., Liu, L., Jin, M., Yu, L., Du, J., Luo, Q., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04265-7 · Cited by 4
“T. gondii infection is known to be associated with neurodegenerative diseases [43], and from our results, we found that TgCtwh3 tachyzoite infection resulted in decreased DJ-1.”
Ozer, E. A., Keskin, A., Berrak, Y. H., Cankara, F., Can, F., Özdemir, Y., Keskin, Ö., Gürsoy, A., & Eser, H. Y. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00128-2 · Cited by 4
“Inflammation, coupled with suppressed neurotrophic factors like BDNF and GDNF, worsens neural plasticity and contributes to cognitive decline [96, 103].”
Ceprián, N., de Toda, I. M., Maté, I., Garrido, A., Giménez‐Llort, L., & la Fuente, M. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136976 · Cited by 7
Herpesvirus initiation of dementias and autoimmune diseases
Roe, K. (2025) · Journal of NeuroVirology · doi:10.1007/s13365-025-01265-8 · Cited by 3
“…(NFTs) and extracellular or intracellular deposits of Aβ, initiating degradation and/or destruction of brain synapses and neurons affecting the hippocampus (Bronzu-oli et al. 2016; Piekut et al. 2022; Piotrowski et al. 2023; Volloch et al. 2020a, 2020b; Eimer et al. 2018; Bubak et al. 2019).”
InfluentialBiosafety and mental health: Virus induced cognitive decline
Du, C., Li, G., & Han, G. (2023) · Biosafety and Health · doi:10.1016/j.bsheal.2023.04.002 · Cited by 3
Tracking Chlamydia – Host interactions and antichlamydial activity in Caenorhabditis elegans
Reigada, I., Kapp, K., Kaudela, T., Soria, M. G., Oksanen, T., & Hanski, L. L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116956 · Cited by 4
Impact of Intermittent Fasting on Alzheimer's Disease Risk: A Literature Review
Stencel, N. J., Szczot, J., Krala-Szkaradowska, M., Skrzypczak, K. O., & Stuczyński, S. K. (2024) · Quality in Sport · doi:10.12775/qs.2024.23.55272 · Cited by 2
Yang, D., Wang, C., Tao, Q., Liu, L., Jin, M., Cai, H., Zheng, M., Gong, M., Yu, L., Du, J., et al. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.009 · Cited by 2
Vitamin deficiencies and Alzheimer’s disease: evidence and implications for supplementation
Miteva, M. T., Laurenti, D., Mattioli, R., Risola, D. D., Mariano, A., & Mosca, L. N. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1676497 · Cited by 4
Prevotella intermedia, an orthodontic point of view
Villarreal, R. D. S., Meester, I., Yamada, J. R., Quevedo, T. D. J. M., Nájera, R. I. S., Gutiérrez, R. G. C., Leon, E. D. C. V., & Soto, J. M. S. (2023) · International Journal of Applied Dental Sciences · doi:10.22271/oral.2023.v9.i3c.1807 · Cited by 2
Liu, Y., Xu, W., Pan, Y., & Liu, X. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240609 · Cited by 2
Infection, Neuroinflammation and Interventions for Healthy Brain and Longevity
Fülöp, T., Ramassamy, C., Lacombe, G., Frost, E. H., Cohen, A. A., Rodrigues, S., Desroches, M., Hirokawa, K., Laurent, B., & Witkowski, J. M. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_12 · Cited by 2
Keränen, E., Rysä, J., Tiihonen, M., Hartikainen, S. A., & Tolppanen, A. (2025) · Epidemiology · doi:10.1097/ede.0000000000001831 · Cited by 2
Editorial: Insights into mechanisms underlying brain impairment in aging, volume II
Dorszewska, J., Ong, K. T., Zabel, M. K., & Marchetti, C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1242271 · Cited by 2
“Many theories have been put forward as to how microorganisms can lead to the development of neurodegeneration, ranging from their ability to interfere with protein trafficking and cause protein aggregation, the activation of microglia toward a pro-inflammatory phenotype consistent with poorer clearance of cellular deb…”
BackgroundSelf-citationCurrent Research on Small Circular Molecules: A Comprehensive Overview on SPHINX/BMMF
Habermann, D., Franz, C. M. A. P., & Klempt, M. (2024) · Genes · doi:10.3390/genes15060678 · Cited by 1
2-es típusú cukorbetegség és Alzheimer-kór − közös mikrobiális gyökerek?
Fekete, C., Schandl, L., Tomasics, G., Egey, A., Kis, J. T., & Winkler, G. (2024) · Orvosi Hetilap · doi:10.1556/650.2024.33128 · Cited by 1
Helicobacter pylori and Cognitive Dysfunction
Beydoun, M. A., & El‐Hajj, Z. W. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780192870414.003.0012 · Cited by 1
Poszwa, J., Słowikowski, B. K., Owecki, W., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., & Dorszewska, J. (2025) · Current Alzheimer Research · doi:10.2174/0115672050390340250716061313 · Cited by 2
Self-citationMa, R., Zhang, Y.-Q., Wang, Y., Liu, Y., Ba, C., & Zhang, M. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1681564 · Cited by 1
“However, emerging evidence links CP infection to chronic obstructive pulmonary disease, asthma, arthritis, cardiovascular disorders, and certain neurological conditions (6, 7).”
InfluentialSalivary microbiome dysbiosis in patients with Alzheimer's disease
Hamdi, A., Stathopoulou, P. M., Gharbi, A., Saadouli, I., Najjari, A., Kacem, I., Ouzari, H., Mokhtar, N. B., Tsiamis, G., Gouider, R., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251393229 · Cited by 1
“8,9 Future tasks are required to build a substantial oral bacterio-mic database and to better understand the underlying oral bacterial causal pathway related to AD.”
Clinical features and chest CT findings of Chlamydia pneumoniae pneumonia
Zheng, H., Qubie, X., Wang, J., Liu, P., & Zhang, W. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1717744 · Cited by 1
The role of microglia in central nervous system injury caused by pathogen infections
Lu, Y., Zhang, C., & Peng, H. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108379 · Cited by 1
Neurodegenerative and Cognitive Consequences of Long COVID
Marek‐Józefowicz, L., Borkowska, A., Nedoszytko, B., Cubała, W. J., Purzycka-Bohdan, D., & Bohdan, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156897 · Cited by 1
“Viral infection is considered an aetiological factor in Alzheimer’s disease [140].”
Grant, W. B., & Wimalawansa, S. J. (2026) · Nutrients · doi:10.3390/nu18172902 · Cited by 1
Nipah virus infection as a putative risk factor for Alzheimer's disease: A testable hypothesis
Ramayanam, N. R., Bukke, S. P. N., Kumar, B. J., Vidiyala, N., Sunkishala, P., Thalluri, C., & Chettupalli, A. K. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261490069 · Cited by 1
Wen, L., Xie, J., Xiao, Q., & He, K. (2023) · Transboundary and Emerging Diseases · doi:10.1155/2023/5909892 · Cited by 2
“…of studies have shown that viruses such as human cytomegalovirus, herpes simplex type 1, 2, and 6A/B, Epstein – Barr virus, hepatitis C virus, in fl uenza virus, Zika virus, and severe acute respiratory syndrome coronavirus 2 may be involved in the development of Alzheimer ’ s disease [27 – 29].”
BackgroundDysregulation of Porphyromonas gingivalis Agmatine Deiminase Expression in Alzheimer’s Disease
Hamdi, A., Baroudi, S., Gharbi, A., Babay, W., Laaribi, A. B., Kacem, I., Mrabet, S., Zidi, I., Klibi, N., Gouider, R., et al. (2024) · Current Alzheimer Research · doi:10.2174/0115672050327009240808103542 · Cited by 1
Alzheimer's disease and increasing the uptake of influenza vaccination
Schattner, A. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.07.016
Metadata
- Authors
- Piekut, T., Hurła, M., Banaszek, N., Szejn, P., Dorszewska, J., Kozubski, W., & Prendecki, M.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Corresponding author
- Dorszewska, Jolanta
- Venue
- Journal of Integrative Neuroscience
- Publisher
- IMR Press
- Published
- 2022-03-28
- Volume
- 21
- Issue
- 2
- Pages
- 73-73
- ISSN
- 0219-6352 (ISSN-L)
- 1757-448X
- OpenAlex
- W4220974380
- Cited by
- 123
- References
- 230
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 42 · 2023: 33 · 2022: 6
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Integrative Neuroscience (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Commission
- Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
- Narodowe Centrum Badań i Rozwoju
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, infectious agents, dementia, amyloid-beta, tau hyperphosphorylation, neuroinflammation, viral pathogens, pathogenic bacteria, Treponema pallidum, Helicobacter pylori, Toxoplasma gondii, SARS-CoV-2, herpes simplex virus, human cytomegalovirus, Epstein-Barr virus, hepatitis C virus, Porphyromonas gingivalis, Fusobacterium nucleatum, oxidative stress, methylation, cognitive decline
- MeSH terms
- COVID-19, SARS-CoV-2, Alzheimer Disease, Herpesvirus 4, Human, Humans, Epstein-Barr Virus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.